Home
>
National Drug Code (NDC)
>
ERBITUX
ERBITUX - 66733-958-23 - (cetuximab)
Drug Information of ERBITUX
| Product NDC: | 66733-958 |
| Proprietary Name: | ERBITUX |
| Non Proprietary Name: | cetuximab |
| Active Ingredient(s): | 2 mg/mL & nbsp; cetuximab |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ERBITUX
| Product NDC: | 66733-958 |
| Labeler Name: | ImClone LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125084 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20071002 |
Package Information of ERBITUX
| Package NDC: | 66733-958-23 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (66733-958-23) > 100 mL in 1 VIAL, SINGLE-USE |
NDC Information of ERBITUX
| NDC Code | 66733-958-23 |
| Proprietary Name | ERBITUX |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (66733-958-23) > 100 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 66733-958 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cetuximab |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20071002 |
| Marketing Category Name | BLA |
| Labeler Name | ImClone LLC |
| Substance Name | CETUXIMAB |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Epidermal Growth Factor Receptor Antagonist [EPC],HER1 Antagonists [MoA] |
